Skip to main content
SpringerLink
Log in

HIV Rapid Testing Programs in Non-Clinical Settings have the Potential to Constitute a Major Diagnostic Option for MSM in Spain

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

We analyze the impact of HIV rapid testing (RT) programs in non-clinical settings (NCS) by evaluating their contribution to new diagnoses reported to the Spanish HIV Surveillance System (SINIVIH) from 2007 to 2012. We estimate the proportion of new diagnoses reported to SINIVIH attributable to them and the maximum annual contribution (MAC). Of 95.575 rapid tests conducted, 2061 were reactive; 1582 in men who have sex with men (MSM). The contribution of RT in NCS increased from 3.4% in 2007 to 11.0% in 2012 (8.1%–16.6% in MSM). RT programs contributed 25.3% of the new diagnoses reported in Catalonia (MAC:30.6%), 15% in the Canary Islands (MAC:16.2%) and 13.7% in the Basque Country (MAC:21.0%). Among MSM, contribution was of 45.2% in Catalonia (MAC:60.7%), 20.2% in the Canary Islands (MAC:21.3%) and 16.6% in the Basque country (MAC:20.9%). Especially among MSM, RT in NCS contributed a large proportion of the new HIV cases diagnosed in regions with a very high HIV incidence.

Resumen

Analizamos el impacto de los programas que ofertan la prueba rápida del VIH en entornos no clínicos (ENC) a través de su contribución a los nuevos diagnósticos notificados al sistema de información sobre nuevos diagnósticos de VIH en España (SINIVIH) en el periodo 2007–2012. Se estima la proporción de nuevos diagnósticos notificados al SINIVIH atribuibles a este tipo de programas y la contribución máxima anual (CMA). De 95.575 prueba rápidas, 2061 fueron reactivas (1582 en hombres que tienen sexo con hombres (HSH)). La contribución de los programas de prueba rápida en ENC creció desde el 3.4% en 2007 hasta el 11.0% en 2012 (8.1%–16.6% en HSH). Estos programas contribuyeron con el 25.3% de los nuevos diagnósticos notificados en Cataluña (CMA:30.6%), 15% en las Islas Canarias (CMA:16.2%) y 13.7% en el País Vasco (CMA:21.0%). Entre los HSH, la contribución fue del 45.2% en Cataluña (CMA:60.7%), 20.2% en las Islas Canarias y 16.6% en el País Vasco (CMA:20.9%). Especialmente entre los HSH, los programas de pruebas rápidas en ENC contribuyeron con una elevada proporción de los nuevos diagnósticos de VIH notificados en regiones de muy alta incidencia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Díaz A, Sobrino P, del Amo J, Moreno S, Díez M. La cascada del tratamiento en España: primeras estimaciones. Málaga: VI Congreso Nacional de GESIDA y 8ª Reunión Docente de la RIS; 2014 (Abstract [P08-1]).

    Google Scholar 

  2. Lundgren JD, Babiker AG, Gordin F, et al. Initiation of Antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.

    Article  CAS  PubMed  Google Scholar 

  3. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308(4):387–402.

    Article  CAS  PubMed  Google Scholar 

  4. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 Infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.

    Article  PubMed  Google Scholar 

  6. Center for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic–United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(15):329–32.

    Google Scholar 

  7. British HIV Association, British Association of Sexual Health and HIV, British Infection Society. UK national guidelines for HIV testing 2008. London: British HIV Association; British Association of Sexual Health and HIV; British Infection Society; 2008.

    Google Scholar 

  8. Secretaría del Plan Nacional sobre el Sida. Plan Multisectorial frente al VIH y el sida. España 2008–2012. http://www.msces/ciudadanos/enfLesiones/enfTransmisibles/sida/docs/PMS200812.pdf. Accessed 2 Nov 2015.

  9. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1–17.

    PubMed  Google Scholar 

  10. European Centre for Disease Prevention and Control. HIV testing: increasing uptake and effectiveness in the European Union. http://ecdc.europa.eu/en/publications/Publications/101129_TER_HIV_testing_evidence.pdf. Accessed 28 Oct 2016.

  11. Belza MJ, Hoyos J, Fernandez-Balbuena S, et al. Assessment of an outreach street-based HIV rapid testing programme as a strategy to promote early diagnosis: a comparison with two surveillance systems in Spain, 2008–2011. Euro Surveill. 2015;20(14):21089.

    Article  PubMed  Google Scholar 

  12. Fernandez-Balbuena S, Belza MJ, Urdaneta E, et al. Serving the underserved: an HIV testing program for populations reluctant to attend conventional settings. Int J Public Health. 2015;60(1):121–6.

    Article  PubMed  Google Scholar 

  13. Fernandez-Balbuena S, Marcos H, Perez-Rubio A, et al. The rapid test in Spanish pharmacies: a novel programme to reach heterosexual men? HIV Med. 2015;16(6):362–9.

    Article  CAS  PubMed  Google Scholar 

  14. Thornton AC, Delpech V, Kall MM, Nardone A. HIV testing in community settings in resource-rich countries: a systematic review of the evidence. HIV Med. 2012;13(7):416–26.

    Article  CAS  PubMed  Google Scholar 

  15. Fernandez-Balbuena S, Belza MJ, Zulaica D, et al. Widening the access to HIV testing: the contribution of three in-pharmacy testing programmes in Spain. PLoS ONE. 2015;10(8):e0134631.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Meulbroek M, Ditzel E, Saz J, et al. BCN checkpoint, a community-based centre for men who have sex with men in Barcelona, Catalonia, Spain, shows high efficiency in HIV detection and linkage to care. HIV Med. 2013;14(Suppl 3):25–8.

    Article  PubMed  Google Scholar 

  17. Qvist T, Cowan SA, Graugaard C, Helleberg M. High linkage to care in a community-based rapid HIV testing and counseling project among men who have sex with men in Copenhagen. Sex Transm Dis. 2014;41(3):209–14.

    Article  PubMed  Google Scholar 

  18. Fernandez-Lopez L, Rifa B, Pujol F, et al. Impact of the introduction of rapid HIV testing in the voluntary counselling and testing sites network of Catalonia, Spain. Int J STD AIDS. 2010;21(6):388–91.

    Article  CAS  PubMed  Google Scholar 

  19. Direccion general de salud pública e innovación Ministerio de Sanidad Servicios Sociales e Igualdad. Informe del cuestionario de actividades de prevención del VIH en las comunidades autónomas. Año 2009. https://www.msssi.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/docs/ICAP2009.pdf. Accessed 28 Oct 2016.

  20. Agência de Salut Pública de Catalunya. Generalitat de Catalunya. Sistema Integrado de Vigilancia Epidemiologica del Sida/VIH/ITS de Cataluña SIVES 2012. Barcelona; 2013. http://www.ceeiscat.cat/documents/SIVES_2012_castellano.pdf. Accessed 28 Oct 2016.

  21. Haute Autorité de Santé. HIV infection screening in France. Paris: Haute Autorité Santé; 2009.

    Google Scholar 

  22. European Centre for Disease Prevention and Control. HIV and STI prevention among men who have sex with men. http://ecdceuropaeu/en/publications/Publications/hiv-sti-prevention-among-men-who-have-sex-with-men-guidance,pdf. Accessed 22 Dec 2015.

  23. de la Fuente L, Delgado J, Hoyos J, et al. Increasing early diagnosis of HIV through rapid testing in a street outreach program in Spain. AIDS Patient Care STDS. 2009;23(8):625–9.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Esteban-Vasallo MD, Dominguez-Berjon MF, Garcia-Riolobos C, et al. Factors associated to a reactive result of rapid-HIV test in socio-culturally adapted services in primary care in Spain. AIDS Behav. 2015;19(12):2370–9.

    Article  CAS  PubMed  Google Scholar 

  25. Seth P, Wang G, Collins NT, Belcher L. Identifying new positives and linkage to HIV medical care—23 testing site types, United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(24):663–7.

    PubMed  Google Scholar 

  26. Walensky RP, Arbelaez C, Reichmann WM, et al. Revising expectations from rapid HIV tests in the emergency department. Ann Intern Med. 2008;149(3):153–60.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Centro Nacional de Epidemiología. Vigilancia Epidemiológica del VIH/SIDA en España. Sistema de información sobre Nuevos Diagnósticos de VIH y Registro Nacional de SIDA. Actualización 30 junio de 2014. http://www.msssigobes/ciudadanos/enfLesiones/enfTransmisibles/sida/vigilancia/InformeVIHSida_Junio2014.pdf. Accessed 12 Nov 2015.

Download references

Acknowledgements

The authors would like to thank all the who have done possible this study especially those working in Projecte dels NOMS Hispanosida, Asociación Madrid Positivo, Osakidetza-Servicio Vasco de Salud, Plan Andaluz frente al VIH/sida y otras ITS, Junta de Andalucía, Agencia de Salud Pública de Barcelona, Médicos del Mundo, Sidálava-Comisión Ciudadana Antisida de Álava, Consejería de Sanidad de Valladolid, Alas-Associacio de lluita anti-sida de les Illes ballears, Lambda Colectiu de lesbians, gais, transsexuals i bisexuals, Dirección de Salud Pública del Servicio Canario de la Salud, Plan galego antiVIH/sida e outras ITS, Bizkaisida-Comisión Ciudadana Antisida de Bizkaia, Associacio Ciutadana Anti-sida de Catalunya, Stop Sida, Dirección General de Salud Pública de Extremadura, Gais Positius, Dirección general de Salud Pública y consumo de la Rioja, SARE-Apoyo VIH/SIDA, Comisión antisida de Navarra, Consejería de Sanidad, consumo y Menores de la Ciudad Autónoma de Ceuta, Área de Vigilancia del VIH y Comportamientos de riesgo Centro Nacional de Epidemiología and Plan Nacional sobre sida in the Ministerio Sanidad Servicios Sociales e Igualdad.

Funding

This study was financed by the Acción stratégica en Salud Intramular (PI14CIII/00009) and by the Consumers, Health and Food Executive Agency Consumers, Health and Food Executive Agency (20131101).

Author information

Authors and Affiliations

  1. CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain

    Sonia Fernández Balbuena, Juan Hoyos, María José Belza & Luis de la Fuente

  2. Departamento de Epidemiología y Bioestadística, Escuela Nacional de Sanidad, Instituto de salud Carlos III, Madrid, Spain

    Juan Hoyos & María José Belza

  3. Projecte dels NOMS Hispanosida, BCN Checkpoint, Barcelona, Spain

    Ferran Pujol

  4. Asociación Madrid Positivo, Madrid, Spain

    Jorge Álvarez

  5. Osakidetza-Servicio Vasco de Salud, San Sebastián, Spain

    Daniel Zulaica

  6. Consejería de Salud de la Junta de Andalucía, Seville, Spain

    Carmen Zamora

  7. Agencia de Salud Pública de Barcelona, Barcelona, Spain

    Benet Rifá & Patricia García-de-Olalla

  8. Médicos del Mundo, Madrid, Spain

    Ramón Esteso

  9. Sidálava-Comisión Ciudadana Antisida de Álava, Vitoria, Spain

    Blanca Bastida

  10. Dirección General de Salud Pública, Consejería de Sanidad, Valladolid, Spain

    María del Henar Marcos

  11. Alas-Associacio de lluita anti-sida de les Illes ballears, Palma de Mallorca, Spain

    Joan Viver

  12. Lambda Colectiu de lesbians, gais, transsexuals i bisexuals, Valencia, Spain

    Julia Talavera

  13. Dirección de Salud Pública del Servicio Canario de la Salud, Santa Cruz de Tenerife, Spain

    Lourdes Capote

  14. Plan galego antiVIH/sida e outras ITS, A Coruña, Spain

    Rogelio Lema

  15. Bizkaisida, Comisión Ciudadana Antisida de Bizkaia, Bilbao, Spain

    Marta Pastor

  16. Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain

    Luis de la Fuente

Authors
  1. Sonia Fernández Balbuena
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan Hoyos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. María José Belza
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ferran Pujol
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jorge Álvarez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Daniel Zulaica
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Carmen Zamora
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Benet Rifá
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Patricia García-de-Olalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ramón Esteso
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Blanca Bastida
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. María del Henar Marcos
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Joan Viver
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Julia Talavera
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Lourdes Capote
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Rogelio Lema
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Marta Pastor
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Luis de la Fuente
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Rapid testing in non-clinical settings evaluation group

  • Ana María Cornejo
  • , Michael Meulbroek
  • , Jorge Gutiérrez
  • , Arantxa Arrillaga
  • , Fernando Lozano
  • , Jose Luis Martinez
  • , Mireia Garcia
  • , Sonia Gil
  • , Elena Urdaneta
  • , Rocio Vitero
  • , Sonia Tamames
  • , Eva García
  • , Marina Valiente
  • , Carles Barres
  • , Cristina Márquez
  • , Jaime Quezadas
  • , Adriana Morales
  • , Gustavo González
  • , Ander Pazos
  • , Eva Martínez
  • , Raquel Turumbay
  • , Asunción Roldán
  • , Irene López
  • , Olivia del Castillo
  •  & Begoña Rodríguez

Corresponding author

Correspondence to Juan Hoyos.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

This is a retrospective study. For this type of study formal consent is not required. Only aggregated data was used in the analysis and no identifying information whatsoever was given by the organizations that run the programmes.

Informed Consent

Informed consent was obtained from all the programme attendees included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Balbuena, S.F., Hoyos, J., Belza, M.J. et al. HIV Rapid Testing Programs in Non-Clinical Settings have the Potential to Constitute a Major Diagnostic Option for MSM in Spain. AIDS Behav 21, 525–533 (2017). https://doi.org/10.1007/s10461-016-1597-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-016-1597-1

Keywords

Search

Navigation